New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery

ACS Medicinal Chemistry Letters
2018.0

Abstract

Nonsense suppressors (NonSups) induce "readthrough", i.e., the selection of near cognate tRNAs at premature termination codons and insertion of the corresponding amino acid into nascent polypeptide. Prior readthrough measurements utilized contexts in which NonSups can promote readthrough directly, by binding to one or more of the components of the protein synthesis machinery, or indirectly, by several other mechanisms. Here we utilize a new, highly purified <i>in vitro</i> assay to measure exclusively direct nonsense suppressor-induced readthrough. Of 16 NonSups tested, 12 display direct readthrough, with results suggesting that such NonSups act by at least two different mechanisms. In preliminary work we demonstrate the potential of single molecule fluorescence energy transfer measurements to elucidate mechanisms of NonSup-induced direct readthrough, which will aid efforts to identify NonSups having improved clinical efficacy.

Knowledge Graph

Similar Paper

New in Vitro Assay Measuring Direct Interaction of Nonsense Suppressors with the Eukaryotic Protein Synthesis Machinery
ACS Medicinal Chemistry Letters 2018.0
New Negamycin-Based Potent Readthrough Derivative Effective against TGA-Type Nonsense Mutations
ACS Medicinal Chemistry Letters 2019.0
PTC124 targets genetic disorders caused by nonsense mutations
Nature 2007.0
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
Journal of Medicinal Chemistry 2009.0
Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations
Bioorganic &amp; Medicinal Chemistry Letters 2022.0
Balancing Nonsense Mutation Readthrough and Toxicity of Designer Aminoglycosides for Treatment of Genetic Diseases
ACS Medicinal Chemistry Letters 2023.0
Design of Novel Aminoglycoside Derivatives with Enhanced Suppression of Diseases-Causing Nonsense Mutations
ACS Medicinal Chemistry Letters 2016.0
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Bioorganic &amp; Medicinal Chemistry 2010.0
Structure–Activity Relationship Study of Leucyl-3-epi-deoxynegamycin for Potent Premature Termination Codon Readthrough
ACS Medicinal Chemistry Letters 2017.0
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs
European Journal of Medicinal Chemistry 2018.0